Skip to main content
CanSino Biologics Inc. logo

CanSino Biologics Inc. — Investor Relations & Filings

Ticker · 6185 ISIN · CNE100003F01 HKEX Manufacturing
Filings indexed 870 across all filing types
Latest filing 2026-05-19 Regulatory Filings
Country HK Hong Kong
Listing HKEX 6185

About CanSino Biologics Inc.

http://www.cansinotech.com

CanSino Biologics Inc. (CanSinoBIO) is an innovative biopharmaceutical company dedicated to the research, development, manufacturing, and commercialization of vaccine products for human use. The company focuses on providing global solutions for the prevention and treatment of infectious diseases. CanSinoBIO leverages advanced technologies and cutting-edge R&D to build its product pipeline, which includes vaccines targeting major public health threats such as meningitis and shingles. Its core strategy centers on exploring and delivering effective solutions for disease prevention worldwide.

Recent filings

Filing Released Lang Actions
Form of Proxy for use at the 2025 Annual General Meeting to be held on Wednesday, June 10, 2026
Regulatory Filings
2026-05-19 English
NOTICE OF 2025 ANNUAL GENERAL MEETING
Regulatory Filings
2026-05-19 English
2025 AGM CIRCULAR
Regulatory Filings
2026-05-19 English
VOLUNTARY ANNOUNCEMENT - THE CENTER FOR DRUG EVALUATION, NMPA GRANTED PRIORITY REVIEW STATUS TO NDA FOR TD5CP ADOLESCENT AND ADULT
Regulatory Filings Classification · 85% confidence The document is a voluntary announcement by CanSino Biologics regarding regulatory status of a drug application (NDA) granted priority review by China’s NMPA. It does not present financial statements, earnings, management changes, dividends, or other specific report content. It is a general regulatory announcement under exchange rules. Therefore, the appropriate classification is Regulatory Filings (RNS).
2026-05-11 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2026-05-06 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 95% confidence The document is very short (242 characters) and is an announcement stating that an announcement has been published elsewhere. It does not contain any substantive financial data or detailed report content. It fits the pattern of a Report Publication Announcement (RPA) rather than the report itself.
2026-04-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.